Format

Send to

Choose Destination
Neurosci Biobehav Rev. 2018 Jun;89:13-28. doi: 10.1016/j.neubiorev.2018.03.020. Epub 2018 Mar 22.

Dopamine D1 and D3 receptor polypharmacology as a potential treatment approach for substance use disorder.

Author information

1
The Graduate Center of the City University of New York, 365 Fifth Avenue, New York, NY 10016, USA.
2
The Graduate Center of the City University of New York, 365 Fifth Avenue, New York, NY 10016, USA; Department of Psychology, Queens College, City University of New York, 65-30 Kissena Blvd, Flushing NY 11367, USA. Electronic address: Robert.Ranaldi@qc.cuny.edu.

Abstract

In the search for efficacious pharmacotherapies to treat cocaine addiction much attention has been given to agents targeting dopamine D1 or D3 receptors because of the involvement of these receptors in drug-related behaviors. D1-like and D3 receptor partial agonists and antagonists have been shown to reduce drug reward, reinstatement of drug seeking and conditioned place preference in rodents and non-human primates. However, translation of these encouraging results to clinical settings has been limited due to a number of factors including toxicity, poor pharmacokinetic properties and extrapyramidal and sedative side effects. This review highlights the role of D1 and D3 receptors in drug reward and seeking, the discovery of D1-D3 heteromers and their potential as targets in the treatment of addiction.

KEYWORDS:

Cocaine; Conditioned place preference; D1 receptors; D3 receptors; Dopamine; Drug addiction; Heteromers; Psychopharmacology; Reinstatement

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center